Mesa Laboratories Inc (MLAB)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 2.82 | 2.81 | 2.92 | 3.07 | 1.84 | 1.64 | 1.66 | 1.68 | 1.71 | 1.75 | 1.80 | 1.80 | 1.82 | 1.52 | 1.54 | 1.48 | 1.51 | 1.50 | 1.51 | 1.91 |
Mesa Laboratories Inc displays strong solvency ratios, as evidenced by consistently low debt-to-assets, debt-to-capital, and debt-to-equity ratios of 0.00 over the period from March 31, 2020, to December 31, 2024. This indicates that the company operates with minimal debt relative to its assets, capital, and equity.
However, it is important to note the trend in the financial leverage ratio, which increased significantly from 1.91 on March 31, 2020, to 2.82 on December 31, 2024. This upward trend suggests that Mesa Laboratories has been using more leverage to finance its operations and growth, which could potentially increase financial risk in the long term.
Overall, while Mesa Laboratories maintains a healthy solvency position with low debt ratios, investors and analysts should closely monitor the trend in the financial leverage ratio to ensure the company's financial risk remains manageable.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | -24.52 | -26.70 | -35.20 | -47.38 | 1.00 | 0.99 | 2.11 | 1.05 | 0.99 | 0.04 | 0.23 | 1.93 | 2.71 | 1.86 | 1.41 | 1.39 | 0.19 | 0.25 | 0.32 | 0.68 |
Mesa Laboratories Inc's interest coverage ratio has shown significant fluctuations over the past few years. The interest coverage ratio measures the company's ability to pay its interest expenses on outstanding debt with its operating income. A higher ratio indicates a stronger ability to cover interest payments.
From March 2020 to December 2021, the interest coverage steadily improved from 0.68 to 2.71, reflecting a better ability to cover interest expenses. However, in the second half of 2022 and the first half of 2023, the ratio dropped significantly, indicating potential challenges in meeting interest obligations.
By the end of December 2023, the interest coverage ratio stabilized around 1.00, suggesting a moderate ability to cover interest payments. In the following periods from March 2024 to December 2024, the interest coverage ratio turned negative, which is concerning as it indicates that the company's operating income was insufficient to cover its interest expenses during those quarters.
Overall, Mesa Laboratories Inc's interest coverage has shown volatility and experienced periods of both improvement and deterioration. It is essential for the company to closely monitor its interest coverage ratio to ensure it maintains a healthy financial position and meets its debt obligations effectively.